디지털 병리학 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 7,411,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,823,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,604,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 디지털 병리학 시장 규모(2024년) : 80억 5,000만 달러
• 시장 규모 예측(2031년) : 172억 달러
• 세계 시장 성장률(2024-2031년) : CAGR 13.5%

시장 성장 촉진요인:

세계 디지털 병리학 시장은 영상 기술의 발전, 만성질환의 유병률 증가, 원격의료 및 원격 진단의 채택 확대 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 디지털 영상의학 솔루션은 보다 빠르고 정확하며 효율적인 진단 프로세스를 제공하여 의료 서비스 제공자가 환자 결과를 개선할 수 있도록 돕습니다. AI와 머신러닝(ML)의 통합으로 진단 정확도와 워크플로우 효율성이 향상되고 있습니다. 또한, 디지털 헬스 기술에 대한 투자 증가와 의료 인프라 개선에 대한 수요도 시장 성장을 촉진하고 있습니다.

시장 억제요인:

디지털 병리학 시장은 성장세를 보이고 있지만, 높은 초기 투자 비용, 기존 의료 시스템과의 통합의 복잡성, 데이터 프라이버시 및 보안에 대한 우려 등의 문제에 직면해 있습니다. 또한, 개발도상국에서의 디지털 병리학 솔루션 도입은 첨단 의료 기술에 대한 접근성이 제한적이고 숙련된 전문가 부족으로 인해 어려움을 겪고 있습니다. 세계 시장에서 디지털 파스퇴르 솔루션의 잠재력을 극대화하기 위해서는 이러한 장벽을 해결해야 합니다.

시장 기회:

기술의 발전, 의료비 지출 증가, 맞춤형 의료의 확대는 이 시장에서 큰 성장 기회를 보여주고 있습니다. 클라우드 기반 플랫폼, AI 기반 진단, 영상 진단 기술 향상 등의 통합은 새로운 성장의 길을 제시하고 있습니다. 또한 분자진단, 의약품 개발 및 연구용 애플리케이션에 대한 수요 증가는 디지털 파스퇴르 솔루션에 큰 비즈니스 기회를 제공하고 있습니다. 또한, 주요 기업, 연구기관, 의료 서비스 제공자 간의 협업은 디지털 파스퇴르 기술의 채택을 촉진하는 데 중요한 역할을 하고 있습니다.

세계의 디지털 병리학 시장을 조사했으며, 시장의 정의와 개요, 시장 촉진·억제요인, 각종 동향, 시장 기회와 과제, 시장 규모(금액, 일부 수량) 추이와 예측, 각종 부문별·지역별·주요 국가별 상세 분석, 경쟁 환경, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위와 정의
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
  • 주요 동향
• 거시경제 요인
  • 세계의 부문별 전망
  • 세계의 GDP 성장 전망
• COVID-19의 영향 분석
• 예측요인 : 관련성과 영향

제3장 부가가치 인사이트

• 제품 채용 분석
• 규제 상황
• 밸류체인 분석
• 주요 거래와 합병
• PESTLE 분석
• Porter's Five Forces 분석
• 상부 시장 분석

제4장 가격 동향 분석

• 주요 하이라이트
• 제품 가격에 영향을 미치는 주요 요인
• 가격 분석(유형별)
• 지역별 가격과 제품 선호

제5장 세계의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
  • 시장 규모 예측
  • 시장 규모·전년비 성장률
  • 수익 기회
• 시장 규모 분석과 예측
• 세계의 디지털 병리학 시장 전망 : 제품별
  • 시장 규모 추정
  • 시장 규모 예측
  • 시장 매력 분석 : 제품
• 세계의 디지털 병리학 시장 전망 : 용도별
  • 시장 규모 추정
  • 시장 규모 예측
  • 시장 매력 분석 : 제품
• 세계의 디지털 병리학 시장 전망 : 최종사용자별
  • 시장 규모 추정
  • 시장 규모 예측
  • 시장 매력 분석 : 제품

제6장 세계의 디지털 병리학 시장 전망 : 지역별

• 주요 하이라이트
• 시장 규모 추정
• 시장 규모 예측
  • 북미
  • 유럽
  • 동아시아
  • 남아시아 및 오세아니아
  • 라틴아메리카
  • 중동 및 아프리카
• 시장 매력 분석 : 지역

제7장 북미의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
  • 국가별
  • 제품별
  • 용도별
  • 최종사용자별
• 시장 규모 분석과 예측 : 국가별
  • 미국
  • 캐나다
• 시장 규모 분석과 예측 : 제품별
  • 디지털 병리학 기기
  • 디지털 병리학 소프트웨어
• 시장 규모 분석과 예측 : 용도별
  • 임상 병리
  • 분자진단
  • 기초 연구·응용 연구
  • 의약품 개발
  • 기타
• 시장 규모 분석과 예측 : 최종사용자별
  • 병원
  • 진단 실험실
  • 제약·바이오테크놀러지 기업
  • 법의학 연구소
  • 연구기관
  • CRO
  • 클리닉
• 시장 매력 분석

제8장 유럽의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
• 시장 규모 분석과 예측 : 국가별
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 러시아
  • 터키
  • 기타
• 시장 규모 분석과 예측 : 제품별
• 시장 규모 분석과 예측 : 용도별
• 시장 규모 분석과 예측 : 최종사용자별
• 시장 매력 분석

제9장 동아시아의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
• 시장 규모 분석과 예측 : 국가별
  • 중국
  • 일본
  • 한국
• 시장 규모 분석과 예측 : 제품별
• 시장 규모 분석과 예측 : 용도별
• 시장 규모 분석과 예측 : 최종사용자별
• 시장 매력 분석

제10장 남아시아 및 오세아니아의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
• 시장 규모 분석과 예측 : 국가별
  • 인도
  • 동남아시아
  • 호주
  • 기타
• 시장 규모 분석과 예측 : 제품별
• 시장 규모 분석과 예측 : 용도별
• 시장 규모 분석과 예측 : 최종사용자별
• 시장 매력 분석

제11장 라틴아메리카의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
• 시장 규모 분석과 예측 : 국가별
  • 브라질
  • 멕시코
  • 기타
• 시장 규모 분석과 예측 : 제품별
• 시장 규모 분석과 예측 : 용도별
• 시장 규모 분석과 예측 : 최종사용자별
• 시장 매력 분석

제12장 중동 및 아프리카의 디지털 병리학 시장 전망 : 추정과 예측

• 주요 하이라이트
• 가격 분석
• 시장 규모 추정
• 시장 규모 분석과 예측 : 국가별
  • GCC 국가
  • 이집트
  • 남아프리카공화국
  • 북아프리카
  • 기타
• 시장 규모 분석과 예측 : 제품별
• 시장 규모 분석과 예측 : 용도별
• 시장 규모 분석과 예측 : 최종사용자별
• 시장 매력 분석

제13장 경쟁 구도

• 시장 점유율 분석
• 시장 구조
• 기업 개요(상세 : 개요, 재무, 전략, 최근 동향)
  • Leica Biosystems(Danaher Corporation)
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm
  • OptraSCAN, Inc.
  • Inspirata, Inc.

제14장 부록

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Digital Pathology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Digital Pathology Market Size (2024E): USD 8.05 Bn
• Projected Market Value (2031F): USD 17.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology refers to the acquisition, management, sharing, and interpretation of pathology information in a digital environment. The market includes various products and services, such as digital pathology equipment, software, and services, that enable the transformation of traditional microscopy and pathology workflows. The growing adoption of digital pathology solutions is driven by factors such as the increasing demand for accurate diagnostics, advancements in telepathology, and the need for efficient and scalable pathology systems in clinical, research, and pharmaceutical settings.

Market Growth Drivers:

The global digital pathology market is driven by several key factors, including advancements in imaging technology, the increasing prevalence of chronic diseases, and the growing adoption of telemedicine and remote diagnostics. Digital pathology solutions provide faster, more accurate, and more efficient diagnostic processes, enabling healthcare providers to improve patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) in digital pathology systems is enhancing diagnostic accuracy and workflow efficiency. Additionally, increasing investments in digital health technologies and the demand for improved healthcare infrastructure are fueling market growth.

Market Restraints:

Despite its promising growth, the digital pathology market faces challenges such as high initial investment costs for equipment, integration complexities with existing healthcare systems, and concerns about data privacy and security. Additionally, the adoption of digital pathology solutions in developing regions is hindered by limited access to advanced healthcare technologies and a lack of skilled professionals. These barriers need to be addressed to unlock the full potential of digital pathology solutions in global markets.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in technology, increased healthcare spending, and the expansion of personalized medicine. The integration of cloud-based platforms, AI-driven diagnostics, and improved imaging techniques offers new avenues for growth. Moreover, the rising demand for molecular diagnostics, drug development, and research applications presents substantial opportunities for digital pathology solutions. Collaborations between key market players, research institutes, and healthcare providers will play a crucial role in advancing the adoption of digital pathology technologies.

Key Questions Answered in the Report:

• What are the primary factors driving the global growth of the digital pathology market?
• Which types of digital pathology products are witnessing the highest adoption across different regions?
• How is the integration of AI and machine learning transforming the digital pathology landscape?
• Who are the leading players in the digital pathology market, and what strategies are they employing to remain competitive?
• What are the emerging trends and future prospects in the digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, such as Danaher Corporation, F. Hoffmann-La Roche AG, and Koninklijke Philips N.V., are focusing on product innovation, strategic partnerships, and acquisitions to maintain their market leadership. These companies are investing heavily in research and development to create advanced digital pathology solutions that integrate AI, machine learning, and cloud technologies. Collaboration with healthcare providers, research institutes, and regulatory bodies is essential for market expansion and adoption. Furthermore, improving the interoperability of digital pathology systems with existing healthcare IT infrastructure is a key strategy for long-term growth.

Key Companies Profiled:

• Danaher Corporation
• F. Hoffmann-La Roche AG
• Huron Technologies International Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• Hamamatsu Photonics K.K.
• Carl Zeiss AG
• Nikon Corporation
• 3DHISTECH Ltd.
• Hologic Inc.
• PerkinElmer, Inc.
• Visiopharm

Digital Pathology Industry Research by Category:

By Product Type:

• Digital Pathology Equipment
• Digital Pathology Software
• Digital Pathology Services

By Application:

• Clinical Pathology
• Molecular Diagnostics
• Basic and Applied Research
• Drug Development
• Others

By End User:

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies
• Forensic Laboratories
• Research Institutes
• Contract Research Organizations (CROs)
• Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• The Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Digital Pathology Market Snapshot, 2024 - 2031
• 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Regulatory Landscape
• 3.3. Value Chain Analysis
• 3.4. Key Deals and Mergers
• 3.5. PESTLE Analysis
• 3.6. Porter's Analysis
• 3.7. Parent Market Analysis

4. Price Analysis, 2023A

• 4.1. Key Highlights
• 4.2. Key Factors Impacting Product Prices
• 4.3. Pricing Analysis, By Product
• 4.4. Regional Prices and Product Preferences

5. Global Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 5.1. Key Highlights
  • 5.1.1. Market Volume (Units) Projections
  • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
  • 5.1.3. Absolute $ Opportunity
• 5.2. Market Size (US$ Bn) Analysis and Forecast
  • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
  • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
• 5.3. Global Digital Pathology Market Outlook: Product
  • 5.3.1. Introduction / Key Findings
  • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2023
  • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 5.3.3.1. Digital Pathology Equipment
      • 5.3.3.1.1. Whole Slide Scanners
      • 5.3.3.1.1.1. Brightfield Slide Scanners
      • 5.3.3.1.1.2. Fluorescence Slide Scanners
      • 5.3.3.1.1.3. Combination Slide Scanners
      • 5.3.3.1.2. Clinical Microscope
      • 5.3.3.1.3. Tissue Microarrays
    • 5.3.3.2. Digital Pathology Software
      • 5.3.3.2.1. Image Viewing and Analysis Software
      • 5.3.3.2.2. Digital Pathology Information Systems
  • 5.3.4. Market Attractiveness Analysis: Product
• 5.4. Global Digital Pathology Market Outlook: Application
  • 5.4.1. Introduction / Key Findings
  • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
  • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 5.4.3.1. Clinical Pathology
    • 5.4.3.2. Molecular Diagnostics
    • 5.4.3.3. Basic & Applied Research
    • 5.4.3.4. Drug Development
    • 5.4.3.5. Others
  • 5.4.4. Market Attractiveness Analysis: Application
• 5.5. Global Digital Pathology Market Outlook: End User
  • 5.5.1. Introduction / Key Findings
  • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
  • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 5.5.3.1. Hospitals
    • 5.5.3.2. Diagnostic Laboratories
    • 5.5.3.3. Pharmaceutical & Biotechnology Companies
    • 5.5.3.4. Forensic Laboratories
    • 5.5.3.5. Research Institutes
    • 5.5.3.6. Contract Research Organizations (CROs)
    • 5.5.3.7. Clinics
  • 5.5.4. Market Attractiveness Analysis: End User

6. Global Digital Pathology Market Outlook: Region

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
• 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
  • 6.3.1. North America
  • 6.3.2. Europe
  • 6.3.3. East Asia
  • 6.3.4. South Asia and Oceania
  • 6.3.5. Latin America
  • 6.3.6. Middle East & Africa
• 6.4. Market Attractiveness Analysis: Region

7. North America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Application
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 7.3.1. U.S.
  • 7.3.2. Canada
• 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 7.4.1. Digital Pathology Equipment
    • 7.4.1.1. Whole Slide Scanners
      • 7.4.1.1.1. Brightfield Slide Scanners
      • 7.4.1.1.2. Fluorescence Slide Scanners
      • 7.4.1.1.3. Combination Slide Scanners
    • 7.4.1.2. Clinical Microscope
    • 7.4.1.3. Tissue Microarrays
  • 7.4.2. Digital Pathology Software
    • 7.4.2.1. Image Viewing and Analysis Software
    • 7.4.2.2. Digital Pathology Information Systems
• 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 7.5.1. Clinical Pathology
  • 7.5.2. Molecular Diagnostics
  • 7.5.3. Basic & Applied Research
  • 7.5.4. Drug Development
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 7.6.1. Hospitals
  • 7.6.2. Diagnostic Laboratories
  • 7.6.3. Pharmaceutical & Biotechnology Companies
  • 7.6.4. Forensic Laboratories
  • 7.6.5. Research Institutes
  • 7.6.6. Contract Research Organizations (CROs)
  • 7.6.7. Clinics
• 7.7. Market Attractiveness Analysis

8. Europe Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Application
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 8.3.1. Germany
  • 8.3.2. France
  • 8.3.3. U.K.
  • 8.3.4. Italy
  • 8.3.5. Spain
  • 8.3.6. Russia
  • 8.3.7. Turkey
  • 8.3.8. Rest of Europe
• 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 8.4.1. Digital Pathology Equipment
    • 8.4.1.1. Whole Slide Scanners
      • 8.4.1.1.1. Brightfield Slide Scanners
      • 8.4.1.1.2. Fluorescence Slide Scanners
      • 8.4.1.1.3. Combination Slide Scanners
    • 8.4.1.2. Clinical Microscope
    • 8.4.1.3. Tissue Microarrays
  • 8.4.2. Digital Pathology Software
    • 8.4.2.1. Image Viewing and Analysis Software
    • 8.4.2.2. Digital Pathology Information Systems
• 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 8.5.1. Clinical Pathology
  • 8.5.2. Molecular Diagnostics
  • 8.5.3. Basic & Applied Research
  • 8.5.4. Drug Development
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 8.6.1. Hospitals
  • 8.6.2. Diagnostic Laboratories
  • 8.6.3. Pharmaceutical & Biotechnology Companies
  • 8.6.4. Forensic Laboratories
  • 8.6.5. Research Institutes
  • 8.6.6. Contract Research Organizations (CROs)
  • 8.6.7. Clinics
• 8.7. Market Attractiveness Analysis

9. East Asia Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Application
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 9.3.1. China
  • 9.3.2. Japan
  • 9.3.3. South Korea
• 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 9.4.1. Digital Pathology Equipment
    • 9.4.1.1. Whole Slide Scanners
      • 9.4.1.1.1. Brightfield Slide Scanners
      • 9.4.1.1.2. Fluorescence Slide Scanners
      • 9.4.1.1.3. Combination Slide Scanners
    • 9.4.1.2. Clinical Microscope
    • 9.4.1.3. Tissue Microarrays
  • 9.4.2. Digital Pathology Software
    • 9.4.2.1. Image Viewing and Analysis Software
    • 9.4.2.2. Digital Pathology Information Systems
• 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 9.5.1. Clinical Pathology
  • 9.5.2. Molecular Diagnostics
  • 9.5.3. Basic & Applied Research
  • 9.5.4. Drug Development
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 9.6.1. Hospitals
  • 9.6.2. Diagnostic Laboratories
  • 9.6.3. Pharmaceutical & Biotechnology Companies
  • 9.6.4. Forensic Laboratories
  • 9.6.5. Research Institutes
  • 9.6.6. Contract Research Organizations (CROs)
  • 9.6.7. Clinics
• 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Application
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 10.3.1. India
  • 10.3.2. Southeast Asia
  • 10.3.3. ANZ
  • 10.3.4. Rest of South Asia & Oceania
• 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 10.4.1. Digital Pathology Equipment
    • 10.4.1.1. Whole Slide Scanners
      • 10.4.1.1.1. Brightfield Slide Scanners
      • 10.4.1.1.2. Fluorescence Slide Scanners
      • 10.4.1.1.3. Combination Slide Scanners
    • 10.4.1.2. Clinical Microscope
    • 10.4.1.3. Tissue Microarrays
  • 10.4.2. Digital Pathology Software
    • 10.4.2.1. Image Viewing and Analysis Software
    • 10.4.2.2. Digital Pathology Information Systems
• 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 10.5.1. Clinical Pathology
  • 10.5.2. Molecular Diagnostics
  • 10.5.3. Basic & Applied Research
  • 10.5.4. Drug Development
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 10.6.1. Hospitals
  • 10.6.2. Diagnostic Laboratories
  • 10.6.3. Pharmaceutical & Biotechnology Companies
  • 10.6.4. Forensic Laboratories
  • 10.6.5. Research Institutes
  • 10.6.6. Contract Research Organizations (CROs)
  • 10.6.7. Clinics
• 10.7. Market Attractiveness Analysis

11. Latin America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Application
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 11.3.1. Brazil
  • 11.3.2. Mexico
  • 11.3.3. Rest of Latin America
• 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 11.4.1. Digital Pathology Equipment
    • 11.4.1.1. Whole Slide Scanners
      • 11.4.1.1.1. Brightfield Slide Scanners
      • 11.4.1.1.2. Fluorescence Slide Scanners
      • 11.4.1.1.3. Combination Slide Scanners
    • 11.4.1.2. Clinical Microscope
    • 11.4.1.3. Tissue Microarrays
  • 11.4.2. Digital Pathology Software
    • 11.4.2.1. Image Viewing and Analysis Software
    • 11.4.2.2. Digital Pathology Information Systems
• 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 11.5.1. Clinical Pathology
  • 11.5.2. Molecular Diagnostics
  • 11.5.3. Basic & Applied Research
  • 11.5.4. Drug Development
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 11.6.1. Hospitals
  • 11.6.2. Diagnostic Laboratories
  • 11.6.3. Pharmaceutical & Biotechnology Companies
  • 11.6.4. Forensic Laboratories
  • 11.6.5. Research Institutes
  • 11.6.6. Contract Research Organizations (CROs)
  • 11.6.7. Clinics
• 11.7. Market Attractiveness Analysis

12. Middle East & Africa Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

• 12.1. Key Highlights
• 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
  • 12.2.1. By Country
  • 12.2.2. By Product
  • 12.2.3. By Application
  • 12.2.4. By End User
• 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
  • 12.3.1. GCC Countries
  • 12.3.2. Egypt
  • 12.3.3. South Africa
  • 12.3.4. Northern Africa
  • 12.3.5. Rest of Middle East & Africa
• 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
  • 12.4.1. Digital Pathology Equipment
    • 12.4.1.1. Whole Slide Scanners
      • 12.4.1.1.1. Brightfield Slide Scanners
      • 12.4.1.1.2. Fluorescence Slide Scanners
      • 12.4.1.1.3. Combination Slide Scanners
    • 12.4.1.2. Clinical Microscope
    • 12.4.1.3. Tissue Microarrays
  • 12.4.2. Digital Pathology Software
    • 12.4.2.1. Image Viewing and Analysis Software
    • 12.4.2.2. Digital Pathology Information Systems
• 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
  • 12.5.1. Clinical Pathology
  • 12.5.2. Molecular Diagnostics
  • 12.5.3. Basic & Applied Research
  • 12.5.4. Drug Development
  • 12.5.5. Others
• 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
  • 12.6.1. Hospitals
  • 12.6.2. Diagnostic Laboratories
  • 12.6.3. Pharmaceutical & Biotechnology Companies
  • 12.6.4. Forensic Laboratories
  • 12.6.5. Research Institutes
  • 12.6.6. Contract Research Organizations (CROs)
  • 12.6.7. Clinics
• 12.7. Market Attractiveness Analysis

13. Competition Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. Market Structure
  • 13.2.1. Competition Intensity Mapping By Market
  • 13.2.2. Competition Dashboard
• 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 13.3.1. Leica Biosystems (Danaher Corporation)
    • 13.3.1.1. Overview
    • 13.3.1.2. Segments and Products
    • 13.3.1.3. Key Financials
    • 13.3.1.4. Market Developments
    • 13.3.1.5. Market Strategy
  • 13.3.2. F. Hoffmann-La Roche AG
  • 13.3.3. Huron Technologies International Inc.
  • 13.3.4. Koninklijke Philips N.V.
  • 13.3.5. Olympus Corporation
  • 13.3.6. Hamamatsu Photonics K.K.
  • 13.3.7. Carl Zeiss AG
  • 13.3.8. Nikon Corporation
  • 13.3.9. 3DHISTECH Ltd.
  • 13.3.10. Hologic Inc.
  • 13.3.11. PerkinElmer, Inc.
  • 13.3.12. Visiopharm
  • 13.3.13. OptraSCAN, Inc.
  • 13.3.14. Inspirata, Inc.

14. Appendix

• 14.1. Research Methodology
• 14.2. Research Assumptions
• 14.3. Acronyms and Abbreviations

관련자료